Skip to main content
Caplight Logo









Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

Private
TianjinHealthcare & Life Scienceshttps://tjsjkt.com/

Last Round

Series B

Sep 20, 2023

Total Funding Raised

$2.94M

Company Overview

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is a medical device company that specializes in the research, development, production, and sale of high-end ophthalmic products, including intraocular lenses, optometry equipment, and biomaterial collagen.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

intraocular lensesIOLophthalmic medical devicesbiomaterial productsmyopia controlcataract surgeryorthokeratologyortho-kcollagen dressingsmedical aestheticssurgical consumablesrigid contact lensesophthalmologyClass III medical deviceswound care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Comparables

Compare Tianjin Century Healthcare Biomedical Engineering Co., Ltd. with similar companies based on industry and business-model similarity.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuxi Vision Pro
89%
Eyebright Medical Technology (Beijing) Co., Ltd.
83%
Shanghai Haohai Biological Technology Co. Ltd
81%

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 20, 2023
Series A ExtensionApr 1, 2023
Series AMay 26, 2022
AngelDec 1, 2021

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Investors

Notable investors and investment history

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. investors
InvestorRounds
SDIC Unity CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2024

    Monthly visitors grew 129% MoM, reaching 384.

  • Sep 20, 2023

    SDIC Unity Capital led the Series B round.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s valuation, stock price, and market status.

Is Tianjin Century Healthcare Biomedical Engineering Co., Ltd. a public or private company?

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is a private company.

What is the current stock price of Tianjin Century Healthcare Biomedical Engineering Co., Ltd.?

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is a private company with no public stock price. Caplight tracks Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Tianjin Century Healthcare Biomedical Engineering Co., Ltd. worth (valuation)?

Valuation information for Tianjin Century Healthcare Biomedical Engineering Co., Ltd. is not publicly available.

Can I buy Tianjin Century Healthcare Biomedical Engineering Co., Ltd. stock?

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s last funding round?

Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s most recent funding round was Series B on September 20, 2023.

Who are the main investors in Tianjin Century Healthcare Biomedical Engineering Co., Ltd.?

Key investors in Tianjin Century Healthcare Biomedical Engineering Co., Ltd. include SDIC Unity Capital.

Will Tianjin Century Healthcare Biomedical Engineering Co., Ltd. IPO soon?

No public IPO plans have been announced for Tianjin Century Healthcare Biomedical Engineering Co., Ltd..

How can I track Tianjin Century Healthcare Biomedical Engineering Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tianjin Century Healthcare Biomedical Engineering Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTianjin
Employee Range5
Year Founded2008
Last FundingSep 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?